Red Ginseng for Neutropenia: Evidence from Clinical Research
This conversation examines whether red ginseng effectively treats neutropenia, based on limited evidence. Only one clinical trial exists, showing no significant benefit over placebo. The discussion emphasizes the need for more research and advises consulting healthcare providers before using supplements for neutropenia, especially during chemotherapy.
Does red ginseng actually help with neutropenia, or is there no evidence it works?
Here's what the evidence shows:
Red Ginseng and Neutropenia — What the Research Says
The research on red ginseng for neutropenia is very limited and not conclusive.
According to Pillser's research database, there is only 1 study examining red ginseng for neutropenia1:
- A 2021 randomized controlled trial looked at Korean red ginseng in bile duct or pancreatic cancer patients undergoing adjuvant chemotherapy.
- The study found that neutropenia prevalence did not differ between the red ginseng group and the control group. The effect was reported as neutral, small, and not statistically significant2.
Aspect Detail Total studies 1 Beneficial 0 Neutral 1 Harmful 0 Bottom Line
At present, there is no solid evidence that red ginseng helps with neutropenia. The only available clinical trial found no significant difference compared to a control group. While red ginseng is sometimes studied for immune modulation, its specific effect on neutrophil counts remains unproven.
If you're looking for supplements for neutropenia, other agents such as vitamin B12, folate, zinc, or specific botanicals might have more supporting evidence — but any use in the context of neutropenia (especially caused by chemotherapy) should be discussed with an oncologist or healthcare provider.
Footnotes
-
Pillser research database, Red Ginseng and Reduced Neutropenia. ↩
-
"Immune-modulating Effect of Korean Red Ginseng by Balancing the Ratio of Peripheral T Lymphocytes in Bile Duct or Pancreatic Cancer Patients With Adjuvant Chemotherapy" (2021), Pillser. ↩